Cargando…
A robust immune-related lncRNA signature for the prognosis of human colorectal cancer
Background: Colorectal cancer (CRC) is one of the most prevalent malignant cancers worldwide. Immune-related long non-coding RNAs (IRlncRNAs) are proved to be essential in the development and progression of carcinoma. The purpose of the present study was to develop and validate a prognostic IRlncRNA...
Autores principales: | Zhu, Gongmin, Pei, Lijiao, Yang, Fan, Zhang, Chenliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301293/ https://www.ncbi.nlm.nih.gov/pubmed/35506372 http://dx.doi.org/10.1042/BSR20220078 |
Ejemplares similares
-
A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma
por: Fu, Xiaorui, et al.
Publicado: (2020) -
Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma
por: Ju, Lincheng, et al.
Publicado: (2022) -
A DCS-related lncRNA signature predicts the prognosis and chemotherapeutic response of patients with gastric cancer
por: Zhang, Yang, et al.
Publicado: (2022) -
Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune‐related lncRNA
por: Shen, Shuang, et al.
Publicado: (2021) -
Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2021)